In Chad, the current pregnant women living with hiv antiretroviral therapy coverage for pmtct is 65%, which reflects a decrease of 8% (-11.0%) compared to 2021.
Pregnant women living with HIV antiretroviral therapy coverage for PMTCT in Chad
No matching regions
Source:
Data availability:
Regions:
215
Date range: 2000 to 2022
Points:
13,975
Measure:
%
More indicators for Chad
Chad PMTCT antiretroviral therapy coverage between 2000 and 2022
| Period | Value | Change |
|---|---|---|
| 2022 | 65% | -8% |
| 2021 | 73% | +1% |
| 2020 | 72% | 0% |
| 2019 | 72% | +7% |
| 2018 | 65% | +10% |
| 2017 | 55% | +5% |
| 2016 | 50% | -3% |
| 2015 | 53% | -15% |
| 2014 | 68% | +20% |
| 2013 | 48% | +19% |
| 2012 | 29% | +7% |
| 2011 | 22% | +4% |
| 2010 | 18% | +7% |
| 2009 | 11% | +2% |
| 2008 | 9% | +5% |
| 2007 | 4% | +1% |
| 2006 | 3% | +3% |
| 2005 | 0% | 0% |
| 2004 | 0% | 0% |
| 2003 | 0% | 0% |
| 2002 | 0% | 0% |
| 2001 | 0% | 0% |
| 2000 | 0% |